Today: 11 June 2026
Micron stock sinks nearly 10% as AI jitters hit chipmakers again
5 February 2026
2 mins read

Micron stock sinks nearly 10% as AI jitters hit chipmakers again

New York, Feb 5, 2026, 09:33 EST — Regular session

Micron Technology (MU.O) shares dropped 9.5% to $379.40 in early Thursday trading, as a wider tech selloff took hold and investors pulled back from crowded AI-related bets.

The slide is significant since Micron has long been seen as a direct barometer for AI infrastructure demand. Now, sharp moves in that trade are rippling through hardware, software, and semiconductor sectors. Traders are less focused on individual earnings beats and more on how quickly risk is being slashed.

Flows played a key role. Goldman Sachs reported that hedge funds faced their toughest day in nearly a year on Wednesday, as crowded tech bets took a hit during a sharp selloff. They called it a momentum unwind — traders chasing price swings instead of fundamentals.

Big Tech’s spending plans sparked fresh tension. Alphabet warned its 2026 capital expenditure might almost double, projecting $175 billion to $185 billion as it boosts investments to tackle compute bottlenecks. CEO Sundar Pichai told analysts that AI infrastructure spending is fueling the company’s growth.

Talk of a memory crunch has shifted from “good for suppliers” to “bad for the chain.” Qualcomm warned its results would miss estimates, citing a global memory shortage that could hurt handset volumes. Executives and analysts pointed to rising memory prices as a headwind for smartphone shipments and chip demand. Reuters

Micron, a top global producer of DRAM and NAND memory, finds itself caught in the middle. While tight supply can push prices up, rising component costs risk crimping device makers’ margins and dragging down sales, particularly in the phone and PC sectors.

The caution was mirrored in related chip stocks. Following Arm’s earnings, Summit Insights analyst Kinngai Chan flagged the steep memory costs facing smartphones as a clear headwind. Investors fretted over the implications of softer device demand for the broader tech ecosystem.

The broader market has felt the strain. A Reuters global markets report flagged a tech selloff spanning several days, driven by worries over soaring costs linked to the AI surge. Chip stocks took a hit, intensifying the sell pressure, while investors are now zeroing in on Amazon’s earnings as a fresh gauge of AI spending.

In software, sentiment echoed similar themes but for other reasons. Societe Generale strategist Manish Kabra predicted cyclical sectors would outperform, while Saxo’s John Hardy flagged rising leverage in markets. Their remarks highlighted why risk assets often move in sync when positioning changes.

Yet Micron bulls face a clear risk: if the selloff morphs into a prolonged shift away from high-multiple AI plays, valuation—not pricing power—could dictate the stock’s direction. On top of that, rising memory costs might prompt customers to slow their builds or cut device production, softening demand even if supply remains constrained.

Investors are eyeing a blend of broader macro trends alongside Micron-specific news. Micron announced that its executives will speak at Wolfe Research’s Auto, Auto Tech and Semiconductor Conference on Feb. 11, which could offer fresh insights on supply and demand. Attention is also turning to Micron’s upcoming quarterly report, with Nasdaq’s earnings calendar currently listing March 19 as an estimated date, not officially confirmed by the company.

Stock Market Today

  • Ideaya Biosciences Stock Drops 10% Amid $300M Fundraising Despite Bullish Outlook
    June 10, 2026, 10:30 PM EDT. Shares of Ideaya Biosciences ($IDYA) fell 10% to around $27 following the announcement of a $300 million stock offering priced at $27 per share, diluting existing shareholder value. The biotech firm had surged 13% earlier due to promising oncology trial results presented at ASCO. Analysts from Citizens reaffirmed a Market Outperform rating and a $45 target, citing robust pipeline developments and collaborations, including a deal with Roche on a novel oncology drug combination. Positive clinical data showed a 37% response rate in uveal melanoma, substantially outperforming standard care. The cash raise aims to advance multiple cancer trials, ensuring a solid financial runway despite near-term stock pressure from dilution.

Latest articles

Tech stocks slide after hours, Oracle’s AI spending draws focus

Tech stocks slide after hours, Oracle’s AI spending draws focus

11 June 2026
Semiconductor stocks plunged 3.6%, dragging the S&P 500 technology sector into correction territory—down 11% from its June 2 record—as investors punished AI-linked companies like Oracle and Super Micro Computer for heavy spending and capital raises, signaling a shift in risk appetite amid rising inflation and escalating U.S.-Iran tensions.
Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

11 June 2026
Murphy USA soared 10.04% to $612.16 as investors seized on Casey’s General Stores’ stronger-than-expected fuel margins, spotlighting sector-wide pump profitability; with Murphy’s own first-quarter fuel contribution up 40.6% and margins at 35.0 cents per gallon, the stock’s jump reflects bets that high margins will persist, though volatility in fuel prices remains a key risk.
Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

11 June 2026
Sky Quarry soared 22.44% to $1.91 on record volume, then jumped to $2.38 after hours, as investors bet on a June refinery restart after repairs and a feedstock shortage crushed Q1 revenue to $383; with just $66,828 in cash and “substantial doubt” about its ability to continue, the stock’s fate hinges on hitting its June production target.
Volvo Car AB stock sinks 22% as Q4 profit slumps and tariffs bite
Previous Story

Volvo Car AB stock sinks 22% as Q4 profit slumps and tariffs bite

Dow Jones drops nearly 300 points as Alphabet AI spending plan rekindles tech jitters
Next Story

Dow Jones drops nearly 300 points as Alphabet AI spending plan rekindles tech jitters

Go toTop